Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 8;47(5):340.
doi: 10.3390/cimb47050340.

Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway

Affiliations

Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway

Neslihan Şahin et al. Curr Issues Mol Biol. .

Abstract

Sepsis-associated acute kidney injury (S-AKI) is a severe complication in critically ill patients, marked by inflammation, oxidative stress, and renal dysfunction. This study aimed to evaluate the renoprotective effects of Fasudil (Fas), a Rho-associated kinase inhibitor, in a rat model of S-AKI induced by cecal ligation and puncture (CLP). Thirty-six Wistar albino rats were divided into control, CLP with saline, and Fas (100 mg/kg/day intraperitoneally) groups. Biochemical, histopathological, and molecular analyses were conducted to assess kidney function, oxidative stress, and inflammation. Fas treatment significantly decreased plasma malondialdehyde and TNF-α levels, reducing oxidative stress and systemic inflammation. Kidney function markers, including BUN and creatinine, showed marked improvement. Furthermore, Fas suppressed the expression of STAT-3 and NLRP-3 in renal tissues, highlighting its role in modulating key inflammatory pathways. Histological evaluation revealed alleviated renal damage, with less tubular necrosis and interstitial inflammation in the Fas-treated group. In conclusion, Fas demonstrates significant anti-inflammatory, antioxidant, and nephroprotective effects in S-AKI, primarily by inhibiting STAT-3 and NLRP-3 signaling. These results support its potential as a therapeutic agent in sepsis-induced kidney injury and suggest the need for further clinical evaluation.

Keywords: Fasudil; NLRP-3 inflammasome; Rho kinase inhibitor; STAT-3 pathway; sepsis-associated acute kidney injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curves for the three groups over 5 days. Statistical comparison is done using the Log-Rank (Mantel–Cox) test.
Figure 2
Figure 2
Histopathological evaluations of the kidney are graphically presented. Results were presented as mean ± SEM. Statistical analyses were performed using one-way ANOVA and a post hoc Bonferroni test. * p < 0.001, different from normal groups; # p < 0.05, ## p < 0.001 different from CLP and saline group.
Figure 3
Figure 3
Kidney histopathology ×10, ×20, and ×40 magnification, hematoxylin and eosin (H&E) stain. (AC) Normal group kidney, renal tubules (t); glomerulus (G); (DF) CLP and saline groups showed severe histopathologic alteration showed kidney injury for tubular dilatation (td), tubular epithelial necrosis (arrow), hemorrhage (H), and luminal necrotic debris (asterisks); (GI) CLP and 100 mg/kg Fasudil groups showed decreased injury for normal tubules (t) and tubular epithelial cells (arrow).

Similar articles

References

    1. Manrique-Caballero C.L., Del Rio-Pertuz G., Gómez H. Sepsis-associated acute kidney injury. Crit. Care Clin. 2021;37:279–301. doi: 10.1016/j.ccc.2020.11.010. - DOI - PMC - PubMed
    1. Bellomo R., Kellum J., Ronco C., Wald R., Martensson J., Maiden M., Bagshaw S.M., Glassford N.J., Lankadeva Y., Vaara S.T., et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43:816–828. doi: 10.1007/s00134-017-4755-7. - DOI - PubMed
    1. Gómez H., Ince C., De Backer D., Pickkers P., Payen D., Hotchkiss J., Kellum J.A. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock. 2014;41:3–11. doi: 10.1097/SHK.0000000000000052. - DOI - PMC - PubMed
    1. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology, needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit. Care. 2004;8:R204–R212. doi: 10.1186/cc2872. - DOI - PMC - PubMed
    1. Okada A., Fukushima K., Fujita M., Nakanishi M., Hamori M., Nishimura A., Shibata N., Sugioka N. Alterations in cisplatin pharmacokinetics and its acute/sub-chronic kidney injury over multiple cycles of cisplatin treatment in rats. Biol. Pharm. Bull. 2017;40:1948–1955. doi: 10.1248/bpb.b17-00499. - DOI - PubMed

LinkOut - more resources